Skip to content

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04604002
Acronym
OCTA
Enrollment
86
Registered
2020-10-27
Start date
2020-10-15
Completion date
2022-01-04
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Vascular, Normal Eyes

Brief summary

Assessment of image quality and clinical relevance of OCT Angiography at different speed/ART combinations

Detailed description

The objectives of this study are: 1.) Compare the image quality between the predicate scan types and the corresponding investigational scan types. 2\. Compare the visibility of key anatomical vascular structures between the predicate scan types and the corresponding investigational scan types. 3\. Assess the agreement in identification of vascular abnormalities between the predicate scan types and the corresponding investigational scan types, where agreement is assessed by the vascular abnormalities identified from the predicate scan types.

Interventions

OCT Angiography offers clinicians a non-invasive three-dimensional visualization of vasculature in the retina and choroid. The visualization of perfused vasculature in a three-dimensional layout, offers clinicians an aid in the identification of retinal and choroidal pathologies such as retinal ischemia, microaneurysms, retinal neovascularization and choroidal neovascular membranes.

Non-contact white light photography

DEVICEOptical Coherence Tomography

A non-contact test that uses light waves to take cross-sectional pictures of the retina

Sponsors

Heidelberg Engineering GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All Populations: 1. Able and willing to undergo the test procedures, sign informed consent, and follow instructions. 2. Age ≥ 22 * Normal Population: 3\. Subjects without uncontrolled systemic conditions, as determined by the Investigator 4. Subjects without ocular disease, as determined by the Investigator 5. Corrected visual acuity ≥ 20/40 6. No reported history of ocular surgical intervention (except for refractive or cataract surgery) * Pathology Population: 3\. Subjects with vascular abnormalities such as retinal ischemia, microaneurysms, choroidal neovascularization, retinal neovascularization in at least one eye

Exclusion criteria

* All Populations: 1. Subjects unable to read or write 2. Subjects with ocular media not sufficiently clear to obtain acceptable study-related imaging 3. Subjects who cannot tolerate the imaging procedures 4. Subjects without an accompanying structural OCT and CFP image for an acceptable OCTA image

Design outcomes

Primary

MeasureTime frameDescription
Image quality scorethrough study completion, an average of 1 dayGraded 0-2 (0 = poor, 1 = average, 2 = good)
Visibility of OCTA key anatomical vascular structures quality scorethrough study completion, an average of 1 dayGraded 0-2 (easy (2), difficult (1) or unable to be distinguished (0)) based on pre-specified abnormalities
Identification of vascular abnormalities on OCTAthrough study completion, an average of 1 dayGraded Yes, No, or Unable to Grade based on pre-specified abnormalities
Adverse Eventsthrough study completion, an average of 1 dayAll AEs

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026